In the present study, we examined the effect of the over-expression of LMNA, or its mutant form progerin (PG), on the mesoderm differentiation potential of mesenchymal stem cells (MSCs) from human umbilical cord (UC) stroma using a recently described differentiation model employing spheroid formation. Accumulation of lamin A (LMNA) was previously associated with the osteoarthritis (OA) chondrocyte phenotype. Mutations of this protein are linked to laminopathies and specifically to Hutchinson-Gilford Progeria Syndrome (HGPS), an accelerated aging disease. Some authors have proposed that a deregulation of LMNA affects the differentiation potential of stem cells. The chondrogenic potential is defective in PG-MSCs, although both PG and LMNA transduced MSCs, have an increase in hypertrophy markers during chondrogenic differentiation. Furthermore, both PG and LMNA-MSCs showed a decrease in manganese superoxide dismutase (MnSODM), an increase of mitochondrial MnSODMdependent reactive oxygen species (ROS) and alterations in their migration capacity. Finally, defects in chondrogenesis are partially reversed by periodic incubation with ROS-scavenger agent that mimics MnSODM effect. Our results indicate that over-expression of LMNA or PG by lentiviral gene delivery leads to defects in chondrogenic differentiation potential partially due to an imbalance in oxidative stress.
Introduction
MSCs are multipotent cells having the capacity to differentiate into various cell lineages, some of which generate bone, cartilage and adipose tissue (Arufe et al., 2011) . Cells expressing MSC markers have been found in many tissues including the synovial membrane and cartilage tissues (Hermida-Gómez et al., 2011) . In addition, osteoarthritic synovial membrane and cartilage contain more cells expressing MSC markers than do synovial membranes from healthy joints (Nagase et al., 2008) . MSCs are likely to be agents of connective tissue homeostasis and repair.
Lamin A and lamin C (A-type lamins, both encoded by the LMNA gene) are major components of the mammalian nuclear lamina, a complex pertinacious structure that acts as a scaffold for protein complexes that regulate nuclear structure and function (Gruenbaum et al., 2003 and Prokocimer et al., 2009) . Mutations in the LMNA gene play a key role in the pathogenesis of a group of diseases called laminopathies, affecting mesoderm tissues (Worman et al., 2010) . One of the most studied laminopathies is Hutchinson-Gilford Progeria Syndrome (HGPS) which is due, in most of the cases, to nuclear accumulation of a permanently farnesylated, mutant form of prelamin A called progerin (PG) (Eriksson et al., 2003) . HGPS is a very rare and fatal genetic disorder characterized by cellular senescence and an early onset of pathologies typical of advanced age such as atherosclerosis, myocardial infarction, stroke or OA (Hennekam, 2006) . Remarkably, PG is also present in normal cells and appears to progressively accumulate during aging of non-HGPS cells (Wang et al., 2008) . Besides producing structural defects in the nuclear lamina, it has also been suggested that PG may interfere with the proposed gene regulatory function of lamins, specifically the regulation of the p16/Rb pathway necessary to maintain balance between differentiation and proliferation of multipotent mesenchymal stromal or stem cells (MSCs) in tissue regeneration (Espada et al., 2008 , Scaffidi and Misteli, 2008 and Hernandez et al., 2010 .
Recently, increased accumulation of lamin A in osteoarthritis (OA) chondrocytes and cartilage (RuizRomero et al., 2008 and Attur et al., 2012) has been reported. OA is one of the most common skeletal disorders clinically manifested by joint pain, swelling and progressive loss of function. It is characterized by cartilage degradation, hypertrophy of the subchondral bone and osteophyte formation at the joint margins (Lamas et al., 2010) . Although the underlying molecular mechanisms involved in the disease remain unknown, the etiology of OA has been considered an articular cartilage disorder induced by mechanical stress, articular injuries, involvement of inflammatory mediators and aging. Evidence suggests that cellular senescence of the chondrocyte is inherent to the OA process (Loeser, 2011) . Finally, progression of the disease has been shown to be therapeutically modulated by MSCs (Mafi et al., 2011 and van Buul et al., 2012) .
The aim of this study was to demonstrate whether lamin A deregulation in MSCs modulates the chondrogenesis process. We demonstrated that over-expression of lamin A and PG reduces the chondrogenic capacity of MSC. We also provided evidence that linked those defects to alterations in oxidative stress response through using N-acetylcysteine which protects against hypoxia produced by production of oxygen reactive species (Cillero-Pastor et al., 2008) .
Material and methods

Tissue collection
Human UCs were obtained from cesarean sections performed on healthy women at the Maternity Facility of Complejo Hospitalario Universitario A Coruña (CHUAC). All tissues were obtained with fully informed consent and ethical approval by the supervisor of the Ethical Committee (CEIC) of Galicia. The UC donors were between 26 and 35 years-old.
Isolation and culture of MSCs
MSCs were isolated from UC stromal tissue using a previously described protocol (Arufe, de la Fuente et al., 2011) . Briefly, the tissue was washed with phosphate-buffered saline (PBS) and cut in small pieces, termed "explants;" which were incubated for three five-minute periods in an enzymatic cocktail containing 1.2 U/mL dispase and 112 U/mL collagenase type I (Sigma-Aldrich, St. Louis, Missouri, USA). The explants were cultured in Dulbecco's Modified Eagles Medium (DMEM) with 10% fetal bovine serum (FBS), 1% penicillin and 1% streptomycin (Sigma-Aldrich) until adhered to the plastic plate. After three days, the explants were removed, leaving the attached UC MSCs, which continued monolayer culture in the same medium. When the cells were 90% confluent, they were removed from the plate using 2% trypsin (Sigma-Aldrich) in PBS and induced to differentiate toward mesoderm cell lines. The cells were characterized by flow cytometry using a FACSAria flow cytometer (BD Bioscience, Madrid, SP) to check the following surface markers: PE-conjugated anti-human CD73 (1:20 from BD Pharmingen); PE-Cy5.5-conjugated mouse anti-human CD90 (1:20 from BD Pharmingen); FITC mouse anti-human CD105: (1:100 from Serotec, Bavaria, Germany); FITC mouse anti-rat CD45 (1:20 BD Pharmingen) and CD34 (1:20 from DakoCytomation, Barcelona, SP). FACS data were generated by DIVA software (BD Bioscience). Negative control staining was performed using FITC-conjugated mouse IgG1k isotype, PE-conjugated mouse IgG1k isotype and PE-Cy5.5-conjugated mouse IgG1k isotype (all from BD Pharmingen). Cells were fixed in 4% paraformaldehyde in PBS. After fixation, the cells were washed twice with PBS, permeabilized with PBS containing 0.1% Triton X-100 (Sigma-Aldrich) for 10 min, then pre-blocked with 3% bovine serum albumin (BSA) and incubated with the different antibodies tested for 30 min at room temperature. The stained cells were then washed twice with PBS and 1 × 10 5 cells were analyzed.
Cloning procedure
Full length human PG, LMNA and green fluorescent protein (GFP) cDNAs were amplified by polymerase chain reaction (PCR) from pBABE-puroGFP-progerin and pBABE-puroGFP-lamin A plasmids (Addgene, donated by Tom Misteli), using the oligonucleotides EcoRI-LMNA-forward: CCGGAATTCATGGAGACCCCGTCCCAGCGG, BamHI-LMNA-reverse: CGCGGATCCTTACATGATGCTGCAGTTCTG, EcoRI-GFP-forward: CCGGAATTCATGGTGAGCAAGGGCGAG, BamHI-GFP-reverse: CGCGGATCCTTACTTGTACACCTCGTC. GFP, LMNA and PG were cloned into pLVX-puro (Clontech Laboratories Inc., Mountain View, CA) in between the EcoRI/BamHI sites following standard cloning procedures.
Lentiviral production
The Lenti-X™ Lentiviral Expression System (Clontech Laboratories Inc.) was used following the manufacturer's protocol. One day before transfection 4 × 10 6 293T producer cells were placed on 100 mm plates in penicillin/streptomycin-free DMEM supplemented with 5% FBS. The following day, three different calcium-phosphate based transfections were performed using LVX-GFP-puro, LVX-Progerinpuro and LVX-lamin A-puro. The cells were incubated overnight with the transfection mixture, then washed with PBS and incubated with 8 mL of fresh complete growth medium.
Viral supernatants were collected at 48 h, 60 h and 72 h following transfection, centrifuged, filtered to remove cell debris and stored at 4 °C until transduction.
Transduction of human UC MSCs
Target cells were plated in 100 mm plates at 6 × 10 6 cells per plate. After one day, the cells were 70% confluent. The cells were incubated sequentially with the 48 hour, 60 hour, and 72 hour viral supernatants for 12 h. Following the last transduction, the cells were washed and incubated with fresh growth medium to allow puromycin-resistance expression. Two days later, puromycin selection was performed by incubating the cells in growth media supplemented with 1 μg/mL puromycin (Clontech Laboratories Inc.) for five days. After selection, transduced cells were washed and allowed to recover in complete media for two days.
Proliferation assay
Different numbers of cells (0, 1000, 2000, 4000, 8000 and 16,000) , plated in triplicate in 96-well plates and allowed to adhere for 8 h, were used to calculate the proliferation curve. The number of cells was then calculated using CellTiter 96® AQueous Non-Radioactive Cell Proliferation Assay (Promega, Madison, WI, USA) following manufacturer's instructions. For the assay, 4000 cells were plated for each cell line in triplicate in 96-well plates, and the total number of cells was calculated at different time points (0, 2, 4 and 6 days).
Chondrogenic differentiation
MSCs transduced with GFP, LMNA or PG were seeded into 96-well plates (Sarstedt, Inc., Barcelona, SP) at 2 × 10 4 cells per well in DMEM with 10% FBS, 1% penicillin, 1% streptomycin, 1.5 × 10 − 4 M monothioglycerol (MTG), 5 mg/mL ascorbic acid (AA), and 6 μg/mL transferrin (TRANS) (all from Sigma-Aldrich) to facilitate spontaneous spheroid formation. The medium was then changed after two days to chondrogenic medium composed of DMEM with 15% knockout serum (Gibco, Invitrogen, Barcelona, SP), 5 mg/mL AA, 6 μg/mL TRANS, 10 μM dexamethasone (DEX), 1 × 10 − 7 M retinoic acid and 1 ng/mL recombinant human transforming growth factor-β3 (rhTGF-β3) (ProSpec-Tany TechnoGene, Deltaclon, Madrid, SP). This medium was changed every three days. After 21 days in the chondrogenic medium, the spheroids formed were collected, frozen and stored at − 80 °C for later analyses. For the N-acetyl-cysteine (NAC) pulses, spheroids were incubated with DMEM, 10% knockout serum (Gibco, Invitrogen), 1% penicillin and 1% streptomycin (Sigma-Aldrich) with 20 μg NAC for 1 h daily for three days prior to regular change of the differentiation media. Control spheroids were incubated under the same conditions in DMEM with 10% knockout serum, 1% penicillin, and 1% streptomycin without NAC.
Adipogenic and osteogenic differentiation
MSCs transfected with LMNA, PG or GFP were seeded into 96-well plates (Sarstedt Inc.) at 2 × 10 4 cells per well in adipogenic or osteogenic commercial medium (Cambrex, Lonza, A Coruña, SP), following the manufacturer's instructions, to assess the mesoderm differentiation potential. Adipogenic cultures were stained with Oil Red O after 21 days of culture. For staining, the culture plates were fixed in 10 mM sodium periodate, 2% paraformaldehyde, 75 mM l-lysine dihydrochloride, and 37.5 mM dibasic sodium phosphate (Sigma-Aldrich) at pH 7.4 for 15 min at room temperature, then air dried and treated with a filtered solution of 0.3% Oil Red O to stain lipid droplets. After 21 days in culture, the osteogenic cultures were stained with alizarin red S to assess calcium deposits. Following fixation, the cells were covered with alizarin red S 2% aqueous solution at pH 4.2 (Sigma-Aldrich) for 3 min, then washed thoroughly with distilled water.
RNA extraction and cDNA synthesis
Total RNA was extracted from cultured cells using the Trizol L.S. reagent method (Invitrogen). Reverse transcription (RT) used the SuperScript II system (Invitrogen). Total RNA (2 μg) was reverse transcribed in a 20 μL reaction volume containing SuperScript II (200 units), random primers (25 μM), and dNTP (0.5 mM each) at 42 °C for 50 min.
Real-time reverse transcriptase PCR (RT-PCR) analysis
The reported sequences of genes for human SOX2 (forward: gtacccgcacttgcacaac; reverse: tcgctctcgttcagaagtctc), Nanog (forward: atgcctcacacggagactgt; reverse: aagtgggttgtttgcctttg), Oct3/4 (forward: ctcctggagggccaggaatc; reverse: atatacacaggccgatgtgg), SOX9 (forward: ctccgggacatgatcagc; reverse: ggtagtgctgggacatgtgaa), lipoprotein lipase (LPL) (forward: agaacatcccattcactctgc; reverse: ccatttgagcttcaacatgagt), fatty acid binding protein (FABP) (forward: ggatgataaactggtggtgga; reverse: cacagaatgttgtagagttcaatc), adiponectin (ADIPOQ) (forward: ggtgagaaaggagatccaggt; reverse: tgctgagcggtatacataggc), alkaline phosphatase (ALP) (forward: gacggacccgtcactctc; reverse: gtgcccgtggtcaattct), osteocalcin (OC) (forward: ggcgctacctgtatcaatgg; reverse: tcagccaactcgtcacagtc), Runx2 (forward: gtgcctaggcgcatttca; reverse: tgactggcggcgtgcaag), aggrecan (AGG) (forward: gcctacgaagcaggctatga; reverse: gcacgccataggtcctga) and RPLP (forward: tctacaaccctgaagtgcttgat; reverse: caatctgcagacagacactgg) as housekeeping were used for primer design. SOX9 was used to check the expression of genes involved in the early chondrogenic stage. Nanog and Sox2 were used to check the expression of genes involved in non-differentiation stages. Genes for human LPL, FABP and ADIPOQ, identified with early and late adipogenic differentiation, and ALP, OC and Runx2 with early and late osteogenic differentiation, were utilized to determine the success of differentiation. The amplification program consisted of an initial denaturation at 92 °C for 2 min followed by 40 cycles from 92 °C for 15 s, annealing at 61 °C for 30 s, and an extension at 72 °C for 15 s. Each PCR analysis was done in duplicate, with each set of assays repeated three times. To minimize effects of unequal quantities of starting RNA and to eliminate potential sources of inconsistency, relative expression levels of each gene were normalized to RPLP using the 2-ΔΔCt method (Livak and Schmittgen, 2001) . Control experiments contained no reverse transcriptase.
Histological, immunofluorescence and immunohistochemical analysis
Spheroids engineered from MSCs following their differentiation into chondrocyte-like cells were frozen in OCT embedding matrix (BDH Chemicals, Poole, UK). Full-depth sections (4 μm) were cut with a cryostat and fixed in 4% (w/v) paraformaldehyde (Sigma-Aldrich) in PBS at pH 7.6. Some sections were stained with safranin O (Sigma-Aldrich) to evaluate the distribution of proteoglycans, others were immunostained with monoclonal antibodies against collagen type 1 (COL1; 1:1000), collagen type 2 (COL2; 1:50) and collagen type 10 (COLX ;1:2000), matrix metalloproteinase-13 (MMP-13; 1:200) and aggrecan (AGG ; 1:50) (Southern Biotechnologies, Birmingham, AL USA) and treated as described by Arufe et al. (2009) . Biotinylated secondary antibodies were detected using a peroxidase-labeled biotinstreptavidin complex (Vectastain Elite kit; Vector Laboratories, Peterborough, UK) with diaminobenzidine substrate (Vector Laboratories) (1:1000). Normal mouse serum was used for the negative control, and the sections were not counterstained.
Control-MSCs and transduced MSCs were grown in 8-chamber slides at a density of 2 × 10 4 cells per chamber. When they reached 80% confluency, cells were fixed with paraformaldehyde 5% in phosphate buffered saline and processed as previously described (Arufe et al., 2009 ) in order to study the nuclear morphology by immunofluorescence using mouse lamin A + C (Acris Antibodies) (1:100) as primary antibody and PE-anti rabbit (BD Science) (1:1000) as secondary antibody.
Densitometry analysis
AnalySIS Image Processing was used to quantify the expression of antibodies obtained by immunohistochemical analyses of sections of spheroids. Three 200 mm 2 fields were quantified for each antibody; immunohistochemistry values were expressed in arbitrary units assigned by computer program. The values were expressed as percentage of positive cells for each of the markers studied.
Immunoblot procedures
Immunoblot analysis was performed on 20 μg of total protein extracted from cells in culture, as previously described (Matsushime et al., 1994) . The antibodies used were mouse lamin A + C (Acris Antibodies), rabbit β-catenin (Santa Cruz Biotech., Santa Cruz, CA), rabbit notch-2 (Santa Cruz Biotech.), rabbit glycerol-3-phosphate dehydrogenase (GPDH) (Amersham), mouse MnSODM (Santa Cruz Biotech.), and rabbit AKT (Cell Signaling, Danvers MA). Secondary anti-mouse and anti-rabbit antibodies (Amersham) were used to visualize proteins by the ECL™ Western Blotting Analysis System (GE Healthcare, Amersham Biotechnology, UK). N = 3. Ideal concentrations for each antibody were determined empirically. Working concentrations were 1:1000 of the stock solutions.
ROS measurement
The percentage of positive cells after treatment with DCFH-DA-2′7′-dichlorofluorescein diacetate (Fluka) was calculated in triplicate as previously described (Cillero-Pastor et al., 2008) . Briefly, 500,000 cells plated in 6-well plates were allowed to grow to 80% confluence, then incubated sequentially with or without NAC for 1 h, washed, and incubated with 10 μM DCFH-DA for 30 min. The cells were then recovered in a tube and analyzed using flow cytometry in a FACSAria instrument (Benton Dickinson). The percentage of positive cells was measured for each condition by fluorescent emission at 488 nm; basal levels calculated from the control without fluorophore were subtracted for each measurement.
Oriented cell migration assay
Cells were detached from regular Petri dishes after reaching a confluence of 80% and 50,000 cells of each cell line were seeded in triplicate on the upper compartment of a modified Boyden's chamber (Corning, Cultek SLU, Madrid, SP) in 200 μL of serum-free medium. The chambers were then introduced in 24-well plates with either serum-free medium or serum-free medium supplemented with 10 ng/mL of stromal cell-derived factor-1 (SDF-1) or 50 pg/mL of interleukin-8 (IL-8) as chemotactic agents. After 24 hour incubation in normoxic conditions, cell migration through the filter were evaluated by trypan-blue cell staining and cell counting in 18 randomly selected microscopy fields.
Statistics
All experiments were done in triplicate and representative results are shown. Statistical analyses used were Student's t test and analysis of variance (ANOVA) using SPSS 16.0 (source). P < 0.05 was considered statistically significant -P < 0.1 for the chondrogenic differentiation with NAC.
Results
LMNA and PG accumulation in LMNA-MSCs and PG-MSCs
The expression of lamin isoforms in GFP-MSCs was similar to their expression in non-transduced MSCs. PG over-expression in PG-MSCs produced alterations in the nuclear membrane (blebs and LMNA accumulation), typical from PG-expressing cell lines (Fig. 1A) . The efficiency of gene delivery and protein expression was determined using immunoblot analysis of the transduced cells with anti-lamin A + C antibody. Ag1972 HGPS cell line was included as a positive control. LMNA-MSCs showed accumulation of wild type (wt) LMNA and its precursor pre-lamin A (PLMNA) (Fig. 1B) . PG-MSCs expressed the lower molecular weight isoform progerin (PG). Mild nuclear defects are only eventually detected in LMNA-MSCs. Furthermore, LMNA and PG over-expressing MSCs show a decrease in their proliferation rate (Fig. 1C) . 
GFP-MSCs differentiation potential comparing to that of non-transduced MSCs
To use the GFP-transduced cells as controls for the differentiation study, we first characterized this cell line. The expression of stem cell genes, including Nanog, Oct4 and Sox9, was not significantly different when GFP-MSCs were compared to non-transduced MSCs as determined by real-time RT-PCR ( Supplementary Fig. 1A ). Primary chondrocytes used as a control did present a significantly (P < 0.05) higher expression of Sox9, an early chondrogenesis gene, compared to GFP-MSCs and non-transduced MSCs (Supplementary Fig. 1A ). The directed differentiation of GFP-MSCs and non-transduced MSCs toward adipogenesis (Supplementary Figs. 1D-F), osteogenesis (Supplementary Figs. 1G-I ) and chondrogenesis ( Supplementary Figs. 1J-L) , did not produce any significant differences between the two cell types when examined by immunohistochemistry and RT-PCR analyses.
Differential potential of PG-MSCs and LMNA-MSCs vs GFP-MSCs
After 21 days in osteogenic medium, almost 100% of the GFP-and LMNA-transduced cells were positive for alizarin red stain, compared with 40% of the PG-MSCs (Figs. 2A-B, Supplementary Fig. 2 ). Genetic studies revealed that LMNA-MSCs expressed the highest level of the OC gene, while PG-MSCs showed the significant (P < 0.05) lowest ALP expression (Fig. 2B) . (Figs. 2C-D, Supplementary Fig. 2 ). The expression of the LPL and FABP genes was significantly (P < 0.05) higher in LMNA-MSCs than in the GFP-MSCs controls, by as much as 100-fold. In contrast, the expression of these genes was lower in PG-MSCs than in GFP-MSCs (Fig. 2D) .
PG-MSCs present a chondrogenic characteristic ratio of COL2 to COL1 significantly much lower than LMNA-MSCs and GFP-MSCs, as revealed by immunohistochemistry (Fig. 3A) and RT-PCR (Fig. 3B) . The histomorphologic study of chondrogenesis demonstrated that PG-MSCs had decreased staining for COL2 and safranin O (proteoglycans) compared to LMNA-MSCs and GFP-MSCs (Fig. 3C and Supplementary Fig. 2 ). These results were corroborated by real-time RT-PCR analysis of COL2 and AGG gene expression (Fig. 3D) . Hypertrophy studies during chondrogenesis used immunohistochemistry to demonstrate the role of LMNA and PG in the process of MSC differentiation. Immunohistochemical analysis of the hypertrophy marker COLX demonstrates that this protein was significantly increased in both PG and LMNA-MSCs (Fig. 3E and Supplementary Fig. 2) ; this finding was validated by real-time RT-PCR (Fig. 3F) . The gene expression of MMP-13, another classical hypertrophy marker, was significantly higher in LMNA and PG-MSCs (Fig. 3F) . In this case, the immunohistochemical analysis showed a significant (P < 0.05) increase of MMP-13 only in PG-MSCs when compared to control GFPMSCs ( Fig. 3E and Supplementary Fig. 2) . 
Role of reactive oxygen species
Western-blot analysis showed that MnSODM expression is diminished in both PG-MSCs and LMNAMSCs compared to the control GFP-MSCs (Fig. 4A) . The spontaneous production of ROS was significantly (P < 0.05) higher in PG-MSCs and LMNA-MSCs than in the control GFP-MSCs (Fig. 4B) . Treatment of the cells for 1 h with NAC reduced the accumulation of ROS from the baseline levels (Fig. 4B) . . Levels of manganese superoxide dismutase (MnSODM), reactive oxygen species ROS production of mesenchymal stem cells (MSCs) transduced with progerin (PG), lamin A (LMNA) or green fluorescent protein (GFP) and the effect on oriented migration capacity. Western blot analysis of the lamin isoforms and MnSODM in the three cell lines (A). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as the housekeeping gene. Flow cytometry of GFP-MSCs, LMNA-MSCs and PGMSCs after one hour incubation with N-acetyl-cysteine (NAC) or treatment with hydrogen peroxide (H2O2) (B). Iso = no treatment; NAC20 = 20 μg NAC; NAC40 = 40 μg NAC; H2O2 = 20 μg; DCFH = 10 μM 2′7′-dichlorofluorescein diacetate control. Modified Boyden's chamber assay of the three cell lines to test their oriented attraction capacity to SDF-1 and IL-8 (C). *P < 0.05 was considered significant using Student's t test versus GFP-MSCs.
Oriented migration capacity of PG-MSCs and LMNA-MSCs in a modified Boyden's chamber assay under the effect of two inflammation-related chemotactic agents, SDF-1 and IL-8, is significantly increased when compared to the control GFP-MSC cell line (Fig. 4C) .
To examine the role of ROS in chondrogenic differentiation of the three MSC lines, we analyzed the effect of NAC on the process. Real-time RT-PCR revealed a statistically significant (P < 0.1) increase in the COL2/COL1 ratio of gene expression levels in cells treated with NAC in the GFP-MSC and LMNA-MSC cell lines (Fig. 5A) . The PG-MSC line was not affected by treatment with NAC, although COL2 gene expression levels were significantly (P < 0.1) higher in NAC-treated compared to NAC-untreated PG-MSCs (data not shown). In NAC-treated cultures, compared to untreated controls, AGG gene expression increased (Fig. 5B ) and MMP-13 gene expression decreased (Fig. 5C ) in LMNA-MSC and PG-MSC cell lines. In GFPMSCs there were no significant changes in AGG and MMP-13 gene expression. As well as the same results were found by immunohistochemistry analysis (Fig. 5D ).
Discussion
We have demonstrated that deregulation of LMNA in our previously characterized chondrogenic model compromised chondrogenic differentiation through, partially, redox imbalance. Lamin A is a key factor regulating both normal and accelerated aging as well as stem cell differentiation. Aging is defined as the accumulation of diverse deleterious changes occurring in cells and tissues with advancing age that are responsible for the increased risk of disease and death (Harman, 2003) . Aging is now considered to be a very complex, multi-factorial process. Several aging theories have been proposed (Tosato et al., 2007) , but no single theory explains all the major age-related physiological changes.
Premature aging syndromes are used as models to partially understand molecular causes of normal aging changes. Among those syndromes, Hutchinson-Gilford Progeria Syndrome (HGPS) is one of the most studied. Recent studies have proposed that stem cell dysfunction enhances both normal and premature aging symptoms (Scaffidi and Misteli, 2008 and Zhang et al., 2011) . To examine that premise in our model of mesoderm line differentiation, and, specifically, chondrogenic differentiation through spheroid formation employing human UC MSCs, we used a lentiviral system to efficiently deliver genes of wt LMNA, PG and GFP, as a control. Gene expression levels were determined by immunoblot; LMNA-MSCs accumulated wt LMNA and PG-MSCs accumulated PG. The low level of PG detected may reflect the low passage number of the cell line, but is similar to the level found in an HGPS-derived fibroblast cell line, AG01972. Besides, nuclear defects and a decrease in the proliferation rate, both typical from PG-expressing, pre-senescent cells, are detected in PG-transduced MSCs. Mild nuclear defects and a decrease in proliferation rate are also detected in LMNA-transduced MSCs, indicating that nuclear accumulation of the wild-type isoform could alter the nuclear lamina similarly to PG accumulation, which agrees with previously published data (Young et al., 2006) . By contrast, GFP-MSCs present similar proliferation rate than non-transduced MSCs. Therefore, we decided to use the GFP-MSCs as control for the differentiation experiments.
We previously characterized MSCs from human umbilical cord stroma by flow cytometry ( Supplementary Fig. 3 ) which showed a similar percentage of positive cells for surface markers CD105, CD90 and CD73 and negative for CD45 and 34 as found in former works by Arufe et al. (2011) . We demonstrated that GFP-MSCs retain a differentiation potential similar to that of non-transduced MSCs. We then used the GFP-MSCs as a control for differentiation experiments for several reasons. Unlike nontransduced MSCs, GFP-MSCs were transduced in parallel with the other cell lines that underwent lentiviral infection and puromycin selection. Also, GFP-MSCs over-express an exogenous protein.
Extensive studies documented in the literature have verified that expression of GFP is innocuous for the cells. Finally, a recently published study demonstrated that lentiviral delivery of GFP into human UC MSCs did not affect their pluripotency (Qian et al., 2010) . Alterations in the mesoderm differentiation potential were seen in the transduced cell lines, where osteogenesis, adipogenesis, and especially chondrogenesis were compromised in PG-MSCs compared to controls. In our model, we found calcium deposits secreted by PG-MSCs to be decreased after 21 days in osteogenic medium compared to GFPMSCs. One possible explanation for this might be the low level of expression of the ALP gene in these cells. In contrast, the significantly higher OC gene expression in LMNA-MSCs may indicate that osteogenesis is not altered in these cells.
After 21 days in adipogenic medium, adipogenic capacity was lessened in PG-MSCs, demonstrated by a significantly lower expression of LPL and FABP genes than in control cells, as well as significantly lower (close to 50%) Oil Red staining. In contrast, LMNA-transduced cells show a significant increase in the expression of those adipogenic markers. Our results differ from those found previously by Kha et al. (2004) . From their results, we would have expected to find an improved osteogenic potential in PG-MSCs because adipogenesis was reduced. One possible explanation for this unexpected result may be that all mechanisms of mesoderm differentiation in PG-MSCs were deregulated as a consequence of the overexpression of PG in our model.
Chondrogenic differentiation in our model is affected by deregulation of LMNA, especially in PGMSCs, as revealed by a lowered COL2/COL1 ratio and lower expression of COL2 and AGG as shown by real-time RT-PCR. While our findings do not completely agree with the results of the study by Scaffidi and Misteli (2008) , any discrepancies may be explained by the different gene delivery methods, different origins of the MSCs, and the different differentiation models employed.
The hypertrophy markers, MMP-13 and COLX, were detected significantly elevated in PG-MSCs by immunohistochemistry, compared to control, after 21 days in chondrogenic medium. Also, LMNA-MSCs presented an increase in COLX, but not in MMP-13. Real-time analysis showed that these two hypertrophy markers were significantly elevated in both PG and LMNA-MSCs. These results were similar to those found in OA chondrocytes . Mitochondrial dysfunction and oxidative stress are known to be responsible for deregulation of chondrogenesis (Ruiz-Romero et al., 2009 and Scott et al., 2010) . We have previously reported that MnSODM is down-regulated in OA and that mitochondrial dysfunction and oxidative stress are responsible for deregulation of chondrogenesis . Hence, we proposed to ascertain whether the diminished chondrogenic potential of LMNA-MSCs and PG-MSCs is linked to defects in MnSODM and oxidative stress imbalance. We investigated MnSODM levels at day 0. Western blot analysis demonstrated a decrease in total MnSODM in both cell lines, which was accompanied by a stable accumulation of ROS. This accumulation is partially, and dose-dependently, reversed by incubation of the cells with the antioxidant compound NAC, which acts as a ROS scavenger. Previously, a rapid and transitory increase in ROS generation in human MSCs from bone marrow has been proposed as the initial factor to sustain the migratory capacity of these cells (Busletta et al., 2011) suggesting a biphasic scenario for in vivo reparation of injured tissues. We decided to study if the migratory capacity in our in vitro model is altered in PG and LMNAoverexpressing umbilical cord MSCs. Modified Boyden's chamber assay shows that these cells present an increased oriented migration capacity activated by two inflammatory chemokines, SDF-1 and IL-8, when compared to control GFP-MSCs. It is not unreasonable to think that the stable increase in ROS generation that we detected in our MSC model when the expression of lamin A is permanently altered, may interfere with the chain of events that leads to a proper migration of this cells.
Gene expression levels of COL2 and COL1 were measured by real-time RT-PCR after 21 days in chondrogenic medium with and without NAC. The COL2/COL1 ratio indicates that NAC treatment improves chondrogenic differentiation. This ratio is significantly higher in GFP-MSCs and LMNAMSCs, comparing NAC-treated and -untreated cells, but not in PG-MSCs, although the COL2 gene expression level was higher in NAC-treated compared to NAC-untreated PG-MSCs (data not shown). The hypertrophy phenotype is lessened by NAC treatment in LMNA-and PG-transduced cells, as shown by increased AGG and decreased MMP-13 gene expression levels. These results indicate that LMNAMSCs and PG-MSCs were more sensitive to NAC treatment because of an accumulation of ROS that correlates with a decrease in MnSODM protein levels. Our results are in agreement with those of Morita et al. indicating that ROS levels regulate the inhibition of proliferation and modulate the initiation of hypertrophic changes in chondrocytes (Morita et al., 2007) and with recent work demonstrating the importance of ROS levels during stem cell differentiation (Hao et al., 2011) (Aly et al., 2011) .
Conclusion
Overall, our results show that chondrogenic differentiation of UC-MSCs is compromised by lamin A deregulation. We also demonstrated that this deregulation alters the oxidative stress balance in MSCs, modifies their migratory properties and induces defects in their capacity to differentiate into chondrocytes in our in vitro model. Further experiments are necessary to determine the in vivo significance of these alterations and to explore putative key targets for stem cell therapies in OA and other aging syndromes.
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